Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 148Thoracic 6Gynecologic 6Head & Neck 4Genitourinary 4Sarcoma 3Lymphoid 2Dermatologic 2Breast 2Plasma cell 1Other neoplasm 1Other hematologic neoplasm 1Other 1Myeloid 1Endocrine 1CNS 1

Conditions

Obesity 219Neoplasms 82Mucositis 66Sexual Dysfunction, Physiological 65Breast Neoplasms 64Polycystic Ovary Syndrome 56Overweight 55Dyspnea 32Motor Activity 30Constipation 30Head and Neck Neoplasms 28Prostatic Neoplasms 25Weight Loss 24Multiple Endocrine Neoplasia Type 1 19Colorectal Neoplasms 18Pain 16Diabetes Mellitus 16Stomatitis 15Lung Neoplasms 15Opioid-Induced Constipation 14Depression 14Cardiovascular Diseases 14Insulin Resistance 13Endometrial Neoplasms 13Sexuality 11Sexual Dysfunctions, Psychological 11Diabetes Mellitus, Type 2 11Fatigue 10Anxiety Disorders 10Stomach Neoplasms 8

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Adenocarcinoma Of Esophagus × Other × Clear all
NCT03813381 2023-10-16

CARE-PRO

Istituto Oncologico Veneto IRCCS

Phase NA Completed
160 enrolled
GastrointestinalOther

Adenocarcinoma Of Esophagus, Barrett Esophagus, Motor Activity, Obesity, Overweight

Data powered by HemOnc (CC BY 4.0) Colophon âš¡